BioMarin Pharmaceutical
BMRN
#1788
Rank
โ‚น1.019 T
Marketcap
โ‚น5,309
Share price
-3.06%
Change (1 day)
-5.69%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: โ‚น1.019 Trillion

As of December 2025 BioMarin Pharmaceutical has a market cap of โ‚น1.019 Trillion. This makes BioMarin Pharmaceutical the world's 1788th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.019 T-6.74%
2024โ‚น1.093 T-27.67%
2023โ‚น1.512 T-5%
2022โ‚น1.591 T31.83%
2021โ‚น1.207 T3.71%
2020โ‚น1.164 T7.37%
2019โ‚น1.084 T2.17%
2018โ‚น1.061 T6.14%
2017โ‚น999.91 B3.28%
2016โ‚น968.18 B-13.9%
2015โ‚น1.124 T31.64%
2014โ‚น854.21 B37%
2013โ‚น623.52 B83.98%
2012โ‚น338.91 B63.16%
2011โ‚น207.72 B55.59%
2010โ‚น133.50 B51.51%
2009โ‚น88.11 B3.17%
2008โ‚น85.40 B-36.7%
2007โ‚น134.91 B102.63%
2006โ‚น66.58 B84.73%
2005โ‚น36.04 B101.93%
2004โ‚น17.84 B-21.25%
2003โ‚น22.66 B24.66%
2002โ‚น18.18 B-46.49%
2001โ‚น33.98 B103.56%
2000โ‚น16.69 B-6.17%
1999โ‚น17.79 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

โ‚น1.052 Trillion
by Nasdaq info icon info icon
โ‚น1.052 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น300.25 B-70.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น13.86 B-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น85.77 B-91.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น10.499 T 929.43%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚น392.65 B-61.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น267.60 B-73.76%๐Ÿ‡บ๐Ÿ‡ธ USA